Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 49 peer-reviewed journal articles Updated
Medical Genetics

Navigating a GSD IV Diagnosis: A Guide for Patients and Families

At a Glance

Glycogen Storage Disease Type IV (GSD IV) is a rare genetic disorder caused by GBE1 gene mutations. It exists on a spectrum, affecting the liver in infants or the nerves and muscles in adults (APBD). Patients require a specialized, multisystemic care team for proper management.

Glycogen Storage Disease Type IV (GSD IV), sometimes called Andersen disease or Adult Polyglucosan Body Disease (APBD), is an extremely rare genetic metabolic disorder. It is estimated to occur in about 1 in 600,000 to 1 in 960,000 live births [1][2].

If you or your child have just been diagnosed, it is completely normal to feel overwhelmed, scared, and confused. The medical terminology can seem like a foreign language, and because the disease is so rare, you might find that you are explaining it to some of your local doctors.

This guide is designed to help you understand the diagnosis, make sense of complex medical terms, and prepare for productive discussions with your care team.

Three Stabilizing Facts You Should Know Now

  1. It is a Spectrum: GSD IV is not one single disease that looks the same in everyone. It operates on a “continuum.” Some forms appear before birth, some primarily affect the liver in childhood, and others (like APBD) only appear in middle adulthood affecting the nerves and muscles [3]. You will not experience every symptom associated with this disease.
  2. It is Multisystemic: Because the body stores glycogen in many different tissues, GSD IV can affect the liver, heart, muscles, and nervous system [4]. You will need a coordinated team of specialists to manage it.
  3. You Are Not Alone: While rare, there is a dedicated community of researchers, metabolic specialists, and patient advocacy groups working on this disease. You will need to find a metabolic expert, but you can build a team to support you.

Navigate the Guide

Please use the links below to explore the specific areas of GSD IV that matter most to you right now:

01

The Science of GSD IV: Why It Happens and How It Differs

Learn the biological causes of Glycogen Storage Disease Type IV (GSD IV). Understand how GBE1 gene mutations affect branching and how it is diagnosed.

02

The Clinical Continuum: Understanding the Symptoms

Understand the symptoms of Glycogen Storage Disease Type IV (GSD IV) and APBD. Learn about the early-onset, hepatic, and adult-onset clinical spectrums.

03

Diagnosis: How to Read Your Pathology and Lab Reports

Learn how to read your GSD IV and APBD pathology reports. Understand PAS-positive inclusions, GBE1 enzyme activity tests, and MRI results for your care.

04

Standard of Care and Treatment Options

Explore standard treatment options for Glycogen Storage Disease Type IV (GSD IV). Learn about liver transplantation, dietary management, and new therapies.

05

Building Your Care Team and Long-Term Monitoring

Learn how to build a multidisciplinary care team for Glycogen Storage Disease Type IV (GSD IV). Understand long-term monitoring for heart and liver health.

Common questions in this guide

What is Glycogen Storage Disease Type IV (GSD IV)?
GSD IV is a rare genetic metabolic disorder where the body cannot properly form and store glycogen. This causes abnormal glycogen structures to build up and potentially damage the liver, heart, muscles, and nervous system.
Does GSD IV affect everyone the same way?
No, GSD IV operates on a clinical spectrum. Some patients experience symptoms in infancy that primarily affect the liver, while others have forms like Adult Polyglucosan Body Disease (APBD) that do not appear until middle adulthood and mainly impact nerves and muscles.
What causes GSD IV?
GSD IV is caused by mutations in the GBE1 gene. These genetic changes result in the formation of abnormal glycogen structures known as polyglucosan bodies, which accumulate in and damage cells.
What specialists do I need on my GSD IV care team?
Because GSD IV can affect multiple organ systems, you will need a metabolic genetics expert to coordinate your care. Depending on your symptoms, your team may also include liver specialists, cardiologists, and neurologists.
What are the treatment options for GSD IV?
Standard care varies widely based on how the disease presents in each patient. Options may include dietary management, liver transplantation for severe childhood liver disease, and exploring experimental therapies.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How much experience does this clinic have treating patients with GBE1 mutations?
  2. 2.Can you help connect us with a metabolic genetics center that specializes in rare glycogen storage diseases?
  3. 3.Who will act as the 'quarterback' for my or my child's care, coordinating between the liver, heart, and nerve specialists?
  4. 4.What immediate next steps or baseline scans do we need to schedule this month?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (4)
  1. 1

    Severe neuromuscular forms of glycogen storage disease type IV: Histological, clinical, biochemical, and molecular findings in a large French case series.

    Lefèvre CR, Collardeau-Frachon S, Streichenberger N, et al.

    Journal of inherited metabolic disease 2024; (47(2)):255-269 doi:10.1002/jimd.12692.

    PMID: 38012812
  2. 2

    Clinical phenotype and trio whole exome sequencing data from a patient with glycogen storage disease IV in Indonesia.

    Harsono IW, Ariani Y, Benyamin B, et al.

    Data in brief 2025; (58()):111231 doi:10.1016/j.dib.2024.111231.

    PMID: 39840231
  3. 3

    A novel approach to characterize phenotypic variation in GSD IV: Reconceptualizing the clinical continuum.

    Kiely BT, Koch RL, Flores L, et al.

    Frontiers in genetics 2022; (13()):992406 doi:10.3389/fgene.2022.992406.

    PMID: 36176296
  4. 4

    Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource.

    Koch RL, Soler-Alfonso C, Kiely BT, et al.

    Molecular genetics and metabolism 2023; (138(3)):107525 doi:10.1016/j.ymgme.2023.107525.

    PMID: 36796138

This guide is for informational purposes only and does not replace professional medical advice. Always consult your metabolic specialist or care team about your specific GSD IV diagnosis and treatment options.

Get notified when new evidence is published on Glycogen Storage Disease Type IV.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.